UBS Q3 2025 Pillar 3: CET1 14.79% and TLAC $199.3B
UBS Group AG furnished its 30 September 2025 Pillar 3 report, detailing stronger capital and liquidity metrics for the quarter.
UBS Group AG furnished its 30 September 2025 Pillar 3 report, detailing stronger capital and liquidity metrics for the quarter. CET1 capital rose to USD 74.7bn with a CET1 ratio of 14.79%, while Tier 1 capital increased to USD 95.0bn. Risk‑weighted assets were USD 504.9bn and the leverage ratio improved to 5.79% on an LRD of USD 1,640.5bn. Available TLAC increased to USD 199.3bn.
Liquidity remained robust: the average LCR was 182.12% with HQLA averaging USD 346.6bn, and the NSFR was 119.68%. Capital movements included operating profit before tax of USD 2.8bn, AT1 issuance equivalent to USD 2.8bn and a USD 1.6bn AT1 call; share repurchases of USD 1.1bn did not materially affect CET1 due to reserve adjustments.
Switzerland is consulting on capital reforms that, if implemented as proposed, would require around USD 24bn additional CET1 at UBS AG, with total incremental CET1 of around USD 39bn when including acquisition‑related requirements; phase‑ins would start no earlier than 2028. FINMA’s 2025 resolution report assessed UBS as resolvable under its preferred bail‑in strategy and called for further development of the Swiss emergency plan.
Positive
- None.
Negative
- None.
Insights
UBS’s Q3 capital and liquidity strengthened; future Swiss rules may lift CET1 needs.
UBS Group reported higher capital: CET1 capital USD 74.7bn and CET1 ratio 14.79%, with USD 95.0bn Tier 1. Available TLAC rose to USD 199.3bn, supported by AT1 issuance equivalent to USD 2.8bn and senior TLAC debt issuance. RWA were broadly stable at USD 504.9bn; the leverage ratio improved to 5.79% on LRD of USD 1,640.5bn.
Liquidity stayed strong with LCR 182.12% and NSFR 119.68%. Within risk, CCR and CVA RWA increased, offset by lower market risk RWA. TLAC growth also reflected new TLAC‑eligible senior unsecured issuance.
Regulatory proposals in Switzerland indicate additional CET1 of around USD 24bn for UBS AG, and in total around USD 39bn including acquisition‑related requirements, with phase‑ins no earlier than 2028. Actual impact depends on final legislative outcomes and phasing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were UBS (UBS) key capital ratios as of 30 September 2025?
How much Total Loss-Absorbing Capacity (TLAC) did UBS report?
What were UBS’s liquidity metrics (LCR and NSFR) in Q3 2025?
How did UBS’s RWA and leverage exposure change in Q3 2025?
What capital market actions affected UBS’s capital this quarter?
What Swiss regulatory changes could affect UBS’s capital?
What did FINMA conclude about UBS’s resolvability?
AI-generated analysis. How Rhea-AI works. Not financial advice.